Investigating β-Lactam Drug Targets in
| Autor: | Samantha R. Levine, Kimberly E. Beatty |
|---|---|
| Rok vydání: | 2021 |
| Předmět: |
0301 basic medicine
Carbapenem Tuberculosis medicine.drug_class 030106 microbiology Cephalosporin Antibiotics beta-Lactams Meropenem Article Microbiology Mycobacterium tuberculosis 03 medical and health sciences chemistry.chemical_compound medicine polycyclic compounds Monobactam Humans Penicillin-Binding Proteins Pathogen 030304 developmental biology chemistry.chemical_classification 0303 health sciences biology 030306 microbiology biochemical phenomena metabolism and nutrition biology.organism_classification medicine.disease bacterial infections and mycoses 3. Good health Enzyme 030104 developmental biology Infectious Diseases chemistry Pharmaceutical Preparations Peptidoglycan medicine.drug |
| Zdroj: | ACS Infect Dis |
| ISSN: | 2373-8227 |
| Popis: | Tuberculosis is a deadly disease that requires a flexible arsenal of drugs to treat it. Although β-lactam antibiotics are rarely used to treat Mycobacterium tuberculosis (Mtb) infections today, the targets of these drugs are present in the bacterium. Moreover, the cell wall peptidoglycan of Mtb contains an abundance of unusual (3→3) cross-links. These cross-links are formed by enzymes called L,D-transpeptidases, which are susceptible to inhibition by the carbapenem class of antibiotics. We developed new small molecule probes to investigate the L,D-transpeptidases and other β-lactam drug targets in Mtb. We synthesized probes based on three classes of antibiotics, a monobactam, cephalosporin, and carbapenem. For the carbapenem, we synthesized a meropenem analogue conjugated to a far-red fluorophore. This probe was particularly useful in identifying active L,D-transpeptidases in protein gel-resolved lysates. Next we analyzed β-lactam targets in lysates from both hypoxic and actively-replicating cultures of Mtb. We identified numerous targets, including transpeptidases, carboxypeptidases, and the β-lactamase BlaC. Overall, we provide evidence that Mtb dynamically regulates the enzymes responsible for maintaining cell wall peptidoglycan and that meropenem is a good inhibitor of those enzymes. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|